Regeneron Pharmaceuticals | REGN - Le Revenu D'Intérêts





Le Revenu D'Intérêts Changement Date
AbbVie USD 72M 13M 2026-03
Agios Pharmaceuticals USD 10.8M 1.62M 2026-03
Alnylam Pharmaceuticals USD 26.6M 32K 2026-03
Astellas Pharma JPY 4.12B 2.94B 2024-03
AstraZeneca USD 80M 7M 2026-06
Biogen USD 37.9M 700K 2026-03
BioMarin Pharmaceutical USD 22.56M 3.35M 2026-03
Eli Lilly USD 65M 25M 2025-09
Gilead Sciences USD 95M 0 2026-03
GlaxoSmithKline GBP 22M 96M 2026-03
Incyte USD 38.12M 4.43M 2026-06
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
J&J USD 2.27 0.13 2026-06
Kyowa Hakko Kirin JPY 2.54B 1.52B 2024-06
Merck USD 35M 34M 2026-03
Moderna USD 72M 2M 2026-03
Pfizer USD -0.04 115M 2026-06
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 183.3M 200K 2026-06
Sanofi EUR 60M 54M 2026-03
Sarepta Therapeutics USD 7M 1.74M 2026-03
Ultragenyx Pharmaceutical USD 6M 512K 2026-03
United Therapeutics USD 31.5M 10.3M 2026-06
Vertex Pharmaceuticals USD 114.8M 7.1M 2026-03